Fisher & Paykel Healthcare Corporation Limited
Simbols: FPH.AX
ASX
23.66
AUDTirgus cena šodien
61.8116
P/E koeficients
3.7087
PEG koeficients
13.82B
MRK Cap
- 0.01%
DIV ienesīgums
Fisher & Paykel Healthcare Corporation Limited (FPH-AX) Finanšu pārskati
Bilance
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 113.3 | 268.5 | 347.2 | |||||||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0.5 | 185.3 | 257.7 | |||||||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 237.9 | 169.2 | 210.5 | |||||||||||||||||||||||
balance-sheet.row.inventory | 0 | 342.4 | 332.4 | 248.8 | |||||||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 31.1 | 52.2 | 39.4 | |||||||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 724.6 | 822.4 | 846 | |||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 1074.7 | 887.2 | 811.1 | |||||||||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 80.1 | 80.4 | 73.6 | |||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 80.1 | 80.4 | 73.6 | |||||||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 93.5 | 84.2 | 102.6 | |||||||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 90.4 | 77.4 | 74.8 | |||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 1338.7 | 1129.2 | 1062 | |||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.total-assets | 0 | 2063.4 | 1951.6 | 1908 | |||||||||||||||||||||||
balance-sheet.row.account-payables | 0 | 40.2 | 49.8 | 52.1 | |||||||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 19.9 | 15.7 | 24.5 | |||||||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 6.2 | 29.5 | 137.6 | |||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 74 | 58.4 | 57.7 | |||||||||||||||||||||||
Deferred Revenue Non Current | 0 | 42.5 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 204.9 | 186.4 | 178.9 | |||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 151 | 114.3 | 116.4 | |||||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 42.5 | 22.5 | 26.7 | |||||||||||||||||||||||
balance-sheet.row.total-liab | 0 | 422.2 | 395.8 | 509.5 | |||||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.common-stock | 0 | 287.3 | 246.7 | 231.1 | |||||||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | 1123.6 | 1094.1 | 946.4 | |||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 233.2 | 219.8 | 223.1 | |||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | -3.1 | -4.7 | -2 | |||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 1641.1 | 1555.9 | 1398.5 | |||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 2063.4 | 1951.6 | 1908 | |||||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.total-equity | 0 | 1641.1 | 1555.9 | 1398.5 | |||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||||||||||||
Total Investments | 0 | 93.5 | 269.5 | 360.4 | |||||||||||||||||||||||
balance-sheet.row.total-debt | 0 | 136.5 | 96.6 | 108.9 | |||||||||||||||||||||||
balance-sheet.row.net-debt | 0 | 23.2 | 13.3 | 19.4 |
Naudas plūsmas pārskats
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 234.3 | 349.1 | 482 | |||||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 92.7 | 88.9 | 78.2 | |||||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 4.5 | -6.3 | -54.3 | |||||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | -250.1 | -216.3 | -214.7 | |||||||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -64.8 | -38.4 | -58.4 | |||||||||||||||||||||||
cash-flows.row.account-receivables | 0 | -40.5 | 48.6 | -4.7 | |||||||||||||||||||||||
cash-flows.row.inventory | 0 | -6.5 | -81.8 | -114.1 | |||||||||||||||||||||||
cash-flows.row.account-payables | 0 | -17.8 | -5.3 | 60.4 | |||||||||||||||||||||||
cash-flows.row.other-working-capital | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 206.4 | 123.4 | 342.2 | |||||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -197.8 | -157.3 | -169.8 | |||||||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | -186.3 | |||||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 187.2 | 74.4 | 0 | |||||||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -10.6 | -82.9 | -356.1 | |||||||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -9.4 | -0.1 | -45.3 | |||||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 2.8 | 3 | 3.2 | |||||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0.9 | 1 | 46.1 | |||||||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -183.2 | -208.3 | -166.7 | |||||||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | 4.3 | -14 | -10.2 | |||||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -184.5 | -218.4 | -172.9 | |||||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 2.4 | 0.2 | -1 | |||||||||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | 30 | -6.2 | 24.5 | |||||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 113.3 | 83.3 | 89.5 | |||||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 83.3 | 89.5 | 65 | |||||||||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 222.9 | 300.4 | 575 | |||||||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -197.8 | -157.3 | -169.8 | |||||||||||||||||||||||
cash-flows.row.free-cash-flow | 0 | 25.2 | 143.1 | 405.1 |
Peļņas vai zaudējumu aprēķina rinda
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 1486.9 | 1521.3 | 1791.4 | |||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 601.6 | 582.6 | 667.2 | |||||||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 885.3 | 938.7 | 1124.2 | |||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.other-expenses | 0 | -7.6 | 40.2 | 32.4 | |||||||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 567.4 | 506.8 | 490.4 | |||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 1168.9 | 1089.4 | 1157.6 | |||||||||||||||||||||||
income-statement-row.row.interest-income | 0 | 2.4 | 2.4 | 1.4 | |||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 6.3 | 4.5 | 4.6 | |||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -11 | 35.1 | 26.6 | |||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | -7.6 | 40.2 | 32.4 | |||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -11 | 35.1 | 26.6 | |||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 6.3 | 4.5 | 4.6 | |||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 92.7 | 88.9 | 78.2 | |||||||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.operating-income | 0 | 318 | 431.9 | 633.8 | |||||||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | 307 | 467 | 660.4 | |||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 72.7 | 117.9 | 178.4 | |||||||||||||||||||||||
income-statement-row.row.net-income | 0 | 250.3 | 376.9 | 524.2 |
Biežāk uzdotie jautājumi
Kas ir Fisher & Paykel Healthcare Corporation Limited (FPH.AX) kopējie aktīvi?
Fisher & Paykel Healthcare Corporation Limited (FPH.AX) kopējie aktīvi ir 2063359237.000.
Kādi ir uzņēmuma gada ieņēmumi?
Gada ieņēmumi ir N/A.
Kāda ir uzņēmuma peļņas norma?
Uzņēmuma peļņas norma ir 0.601.
Kāda ir uzņēmuma brīvā naudas plūsma?
Brīvā naudas plūsma ir 0.051.
Kāda ir uzņēmuma neto peļņas norma?
Neto peļņas norma ir 0.153.
Kādi ir uzņēmuma kopējie ieņēmumi?
Kopējie ieņēmumi ir 0.219.
Kāda ir Fisher & Paykel Healthcare Corporation Limited (FPH.AX) tīrā peļņa (tīrie ienākumi)?
Tīrā peļņa (tīrie ienākumi) ir 250300000.000.
Kāds ir uzņēmuma kopējais parāds?
Kopējais parāds ir 136465310.000.
Kāds ir pamatdarbības izdevumu skaits?
Darbības izdevumi ir 567388691.000.
Kāds ir uzņēmuma skaidrās naudas rādītājs?
Uzņēmuma nauda ir 0.000.